Insights

Stop Asking Who the GLP-1 Oral Patient Is. Start Asking What They Need Next.

Every commercial team with or developing an oral GLP-1 to market right now is chasing a ghost: the...

Are We Measuring GLP-1 Success Too Narrowly?

GLP-1 receptor agonists have transformed the treatment landscape for obesity and diabetes, and for...

If GLP-1 Therapies Are Approved for Type 1 Diabetes, Patient Support Will Matter as Much as the Medication

For more than 100 years, nearly every major breakthrough in type 1 diabetes has focused on one...

How Target Patients Ranked the 2026 Super Bowl Commercials for GLP-1 Drugs

The 2026 Super Bowl wasn’t just a showdown on the field, it was a battle of brands off of it. As...

From Gut Feel to Clarity: 3 Steps to Smarter Brand Decisions

Every commercial and brand leader has experienced it: the monthly performance review where...

Breaking Down Barriers: Why Are Only 31% of Type 2 Patients on GLP-1s?

GLP-1 receptor agonists such as Ozempic, Wegovy, and Mounjaro are transforming the care of type 2...

The Best Hacks to Get Participants to Participate in Your Research Study

Recruiting participants for noninterventional healthcare market research or clinical trial lead...

Common Pitfalls in Healthcare and Pharmaceutical Research Studies and How to Avoid Them

Research studies are essential to advancing healthcare and pharmaceutical innovations, whether for...

Empowering CKD Patient Engagement and Insights with Thrivable

Chronic kidney disease (CKD) is a condition that affects millions across the country. Currently,...

What Happens When You Neglect Listening to Patients in MedTech Development?

Imagine launching a revolutionary medtech device, only to see it fail spectacularly—not because the...